HIV/AIDS Testing
Chembio receives CLIA Waiver for HIV 1/2 STAT-PAK
Published in Medical Letter on the CDC and FDA, December 31st, 2006
The CLIA (Clinical Laboratory Improvement Act) waiver allows Chembio to market these HIV tests to a potential market of approximately 189,000 laboratory entities across the United States, including doctors' offices and clinics.
Larry Siebert, chief executive officer of Chembio, said, "CLIA Waiver is an important milestone, as this now allows us to submit final labeling changes to the FDA for marketing by Inverness Medical Innovations (IMA), our U.S. marketing partner for this product. These changes will be submitted during...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- FDA
Data on FDA detailed by researchers at Milton S. Hershey Medical Center - FDA
Researchers from University of California, Division of Plastic Surgery describe findings in FDA - FDA
Researchers from University of Illinois, Center for Health publish findings in FDA in children - FDA
Scientists at Santa Clara Valley Medical Center, Department of Internal Medicine detail research in FDA - Amyotrophic Lateral Sclerosis
CytRx Phase IIa Arimoclomol data presented at 17th International Symposium on ALS/MND - Atrial Fibrillation
CryoCath Technologies receives U.S. FDA approval to expand atrial fibrillation trial - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
